185 related articles for article (PubMed ID: 36054818)
1. The immunosuppression pathway of tumor-associated macrophages is controlled by heme oxygenase-1 in glioblastoma patients.
Magri S; Musca B; Pinton L; Orecchini E; Belladonna ML; Orabona C; Bonaudo C; Volpin F; Ciccarino P; Baro V; Della Puppa A; Mandruzzato S
Int J Cancer; 2022 Dec; 151(12):2265-2277. PubMed ID: 36054818
[TBL] [Abstract][Full Text] [Related]
2. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
3. Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow-Derived Macrophages.
Wu M; Wu L; Wu W; Zhu M; Li J; Wang Z; Li J; Ding R; Liang Y; Li L; Zhang T; Huang B; Cai Y; Li K; Li L; Zhang R; Hu B; Lin F; Wang X; Zheng S; Chen J; You Y; Jiang T; Zhang J; Chen H; Wang Q
Cancer Res; 2023 Mar; 83(5):771-785. PubMed ID: 36622331
[TBL] [Abstract][Full Text] [Related]
4. The Diverse Roles of Heme Oxygenase-1 in Tumor Progression.
Luu Hoang KN; Anstee JE; Arnold JN
Front Immunol; 2021; 12():658315. PubMed ID: 33868304
[TBL] [Abstract][Full Text] [Related]
5. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
6. Interaction between PD-L1 and soluble VEGFR1 in glioblastoma-educated macrophages.
Liu X; Li Z; Sun J; Zhang Z; Li W
BMC Cancer; 2023 Mar; 23(1):259. PubMed ID: 36941554
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer cell debris diminishes therapeutic efficacy through heme oxygenase-1-mediated inactivation of M1-like tumor-associated macrophages.
Kim SH; Saeidi S; Zhong X; Gwak SY; Muna IA; Park SA; Kim SH; Na HK; Joe Y; Chung HT; Kim KE; Han W; Surh YJ
Neoplasia; 2020 Nov; 22(11):606-616. PubMed ID: 33039895
[TBL] [Abstract][Full Text] [Related]
8. M2 tumor-associated macrophages resist to oxidative stress through heme oxygenase-1 in the colorectal cancer tumor microenvironment.
Ito M; Mimura K; Nakajima S; Okayama H; Saito K; Nakajima T; Kikuchi T; Onozawa H; Fujita S; Sakamoto W; Saito M; Momma T; Saze Z; Kono K
Cancer Immunol Immunother; 2023 Jul; 72(7):2233-2244. PubMed ID: 36869896
[TBL] [Abstract][Full Text] [Related]
9. Heme oxygenase-1 orchestrates the immunosuppressive program of tumor-associated macrophages.
Alaluf E; Vokaer B; Detavernier A; Azouz A; Splittgerber M; Carrette A; Boon L; Libert F; Soares M; Le Moine A; Goriely S
JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32369450
[TBL] [Abstract][Full Text] [Related]
10. Heme catabolism by tumor-associated macrophages controls metastasis formation.
Consonni FM; Bleve A; Totaro MG; Storto M; Kunderfranco P; Termanini A; Pasqualini F; Alì C; Pandolfo C; Sgambelluri F; Grazia G; Santinami M; Maurichi A; Milione M; Erreni M; Doni A; Fabbri M; Gribaldo L; Rulli E; Soares MP; Torri V; Mortarini R; Anichini A; Sica A
Nat Immunol; 2021 May; 22(5):595-606. PubMed ID: 33903766
[TBL] [Abstract][Full Text] [Related]
11. TLR4 activation alters labile heme levels to regulate BACH1 and heme oxygenase-1 expression in macrophages.
Sudan K; Vijayan V; Madyaningrana K; Gueler F; Igarashi K; Foresti R; Motterlini R; Immenschuh S
Free Radic Biol Med; 2019 Jun; 137():131-142. PubMed ID: 31026585
[TBL] [Abstract][Full Text] [Related]
12. Heme Oxygenase-1 expression in M-CSF-polarized M2 macrophages contributes to LPS-induced IL-10 release.
Sierra-Filardi E; Vega MA; Sánchez-Mateos P; Corbí AL; Puig-Kröger A
Immunobiology; 2010; 215(9-10):788-95. PubMed ID: 20580464
[TBL] [Abstract][Full Text] [Related]
13. Superinduction of immunosuppressive glioblastoma extracellular vesicles by IFN-γ through PD-L1 and IDO1.
Jung MY; Aibaidula A; Brown DA; Himes BT; Cumba Garcia LM; Parney IF
Neurooncol Adv; 2022; 4(1):vdac017. PubMed ID: 35990703
[TBL] [Abstract][Full Text] [Related]
14. PD-L1-Mediated Immunosuppression in Glioblastoma Is Associated With the Infiltration and M2-Polarization of Tumor-Associated Macrophages.
Zhu Z; Zhang H; Chen B; Liu X; Zhang S; Zong Z; Gao M
Front Immunol; 2020; 11():588552. PubMed ID: 33329573
[TBL] [Abstract][Full Text] [Related]
15. Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression.
Pu Y; Ji Q
Front Immunol; 2022; 13():874589. PubMed ID: 35592338
[TBL] [Abstract][Full Text] [Related]
16. The role of extracellular vesicles and PD-L1 in glioblastoma-mediated immunosuppressive monocyte induction.
Himes BT; Peterson TE; de Mooij T; Garcia LMC; Jung MY; Uhm S; Yan D; Tyson J; Jin-Lee HJ; Parney D; Abukhadra Y; Gustafson MP; Dietz AB; Johnson AJ; Dong H; Maus RL; Markovic S; Lucien F; Parney IF
Neuro Oncol; 2020 Jul; 22(7):967-978. PubMed ID: 32080744
[TBL] [Abstract][Full Text] [Related]
17. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma.
Zhang W; Liu Y; Yan Z; Yang H; Sun W; Yao Y; Chen Y; Jiang R
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581055
[TBL] [Abstract][Full Text] [Related]
18. Novel roles of c-Met in the survival of renal cancer cells through the regulation of HO-1 and PD-L1 expression.
Balan M; Mier y Teran E; Waaga-Gasser AM; Gasser M; Choueiri TK; Freeman G; Pal S
J Biol Chem; 2015 Mar; 290(13):8110-20. PubMed ID: 25645920
[TBL] [Abstract][Full Text] [Related]
19. Local Targeting of NAD
Li M; Kirtane AR; Kiyokawa J; Nagashima H; Lopes A; Tirmizi ZA; Lee CK; Traverso G; Cahill DP; Wakimoto H
Cancer Res; 2020 Nov; 80(22):5024-5034. PubMed ID: 32998997
[TBL] [Abstract][Full Text] [Related]
20. Bach1 regulates osteoclastogenesis in a mouse model via both heme oxygenase 1-dependent and heme oxygenase 1-independent pathways.
Hama M; Kirino Y; Takeno M; Takase K; Miyazaki T; Yoshimi R; Ueda A; Itoh-Nakadai A; Muto A; Igarashi K; Ishigatsubo Y
Arthritis Rheum; 2012 May; 64(5):1518-28. PubMed ID: 22127667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
